Template:Septic Bursitis Antibiotics: Difference between revisions
No edit summary |
Ostermayer (talk | contribs) |
||
| Line 2: | Line 2: | ||
====Outpatient Options==== | ====Outpatient Options==== | ||
*[[Clindamycin]] 300 mg PO three times daily x | *[[Clindamycin]] 300 mg PO three times daily x 14 days '''OR''' | ||
*[[TMP/SMX]] 2 DS tabs PO two times daily x | *[[TMP/SMX]] 2 DS tabs PO two times daily x 14 days '''OR''' | ||
*[[Dicloxacillin]] 500mg PO q6hr x10 days | *[[Dicloxacillin]] 500mg PO q6hr x10 days | ||
''Treatment followup with primary physician is important since the regimen may need extension to 3 weeks.'' | |||
====Inpatient Options==== | ====Inpatient Options==== | ||
*[[Vancomycin]] 15-20 mg/kg IV BID '''OR''' | *[[Vancomycin]] 15-20 mg/kg IV BID '''OR''' | ||
*[[Clindamycin]] 600 mg IV three times daily | *[[Clindamycin]] 600 mg IV three times daily | ||
Revision as of 15:59, 18 January 2019
Cover Staphylococcus aureus (80-90%) and Streptococcus
Outpatient Options
- Clindamycin 300 mg PO three times daily x 14 days OR
- TMP/SMX 2 DS tabs PO two times daily x 14 days OR
- Dicloxacillin 500mg PO q6hr x10 days
Treatment followup with primary physician is important since the regimen may need extension to 3 weeks.
Inpatient Options
- Vancomycin 15-20 mg/kg IV BID OR
- Clindamycin 600 mg IV three times daily